These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14686306)

  • 41. HIV drug resistance--a chink in the armor.
    Hirsch MS
    N Engl J Med; 2002 Aug; 347(6):438-9. PubMed ID: 12167687
    [No Abstract]   [Full Text] [Related]  

  • 42. Antiretroviral drug resistance testing: potential use following nosocomial exposure to HIV.
    Worthington M
    Clin Infect Dis; 2003 Dec; 37(12):1722-3. PubMed ID: 14689361
    [No Abstract]   [Full Text] [Related]  

  • 43. Genotypic resistance tests for the management of postexposure prophylaxis.
    Puro V
    Scand J Infect Dis Suppl; 2003; 106():93-8. PubMed ID: 15000596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure.
    Montroni M; Monforte AD
    Scand J Infect Dis Suppl; 2003; 106():79-81. PubMed ID: 15000591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current concepts in antiretroviral therapy failure.
    del Rio C
    Top HIV Med; 2006; 14(3):102-6. PubMed ID: 16946454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New developments in HIV drug resistance.
    Cane PA
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i37-40. PubMed ID: 19675018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retrospective analysis of antiretroviral HIV treatment success based on medical history or guided by the reverse hybridisation LiPA HIV genotyping system.
    Alvarez M; García F; Martínez NM; Hernández Quero J; Louwagie J; De Brauwer A; Maroto MC
    J Med Virol; 2004 Jun; 73(2):151-7. PubMed ID: 15122786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiretroviral rounds. Resistance: how do you know if you don't know?
    Campbell TB; Katzenstein D
    AIDS Clin Care; 2005 Mar; 17(3):26-7. PubMed ID: 15828117
    [No Abstract]   [Full Text] [Related]  

  • 50. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
    Bassetti D; Cargnel A
    Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding transmitted HIV resistance through the experience in the USA.
    Taiwo B
    Int J Infect Dis; 2009 Sep; 13(5):552-9. PubMed ID: 19136289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV susceptibility testing--time for standards.
    Hill AM; Telenti A
    Antivir Ther; 2004 Aug; 9(4):463-4. PubMed ID: 15456076
    [No Abstract]   [Full Text] [Related]  

  • 53. Running with scissors: using antiretroviral therapy without monitoring viral load.
    Smith DM; Schooley RT
    Clin Infect Dis; 2008 May; 46(10):1598-600. PubMed ID: 18419496
    [No Abstract]   [Full Text] [Related]  

  • 54. HIV resistance: frequency, testing, mechanisms.
    Kuritzkes DR
    Top HIV Med; 2007; 15(5):150-4. PubMed ID: 18073450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection.
    Booth CL; Geretti AM
    J Antimicrob Chemother; 2007 Jun; 59(6):1047-56. PubMed ID: 17449483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.
    Escoto-Delgadillo M; Vázquez-Valls E; Ramírez-Rodríguez M; Corona-Nakamura A; Amaya-Tapia G; Quintero-Pérez N; Panduro-Cerda A; Torres-Mendoza BM
    HIV Med; 2005 Nov; 6(6):403-9. PubMed ID: 16268822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
    Cozzi-Lepri A; Phillips AN; Clotet B; Mocroft A; Ruiz L; Kirk O; Lazzarin A; Wiercinska-Drapalo A; Karlsson A; Lundgren JD;
    AIDS; 2008 Oct; 22(16):2187-98. PubMed ID: 18832882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Flexibility in avoiding resistance].
    Holzgrabe U
    Pharm Unserer Zeit; 2004; 33(5):349. PubMed ID: 15497326
    [No Abstract]   [Full Text] [Related]  

  • 59. New horizons in antiretroviral drug resistance.
    Geretti AM
    J HIV Ther; 2007 Dec; 12(4):81-2. PubMed ID: 18391891
    [No Abstract]   [Full Text] [Related]  

  • 60. Developments in HIV treatments: strategies for success.
    Piliero P
    AIDS Read; 2004 Dec; 14(12):655-65. PubMed ID: 15619781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.